Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05967689 |
|---|---|
| Brief Title: | A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation. (REZILIENT2) |
| First Submitted : | July 11, 2023 |
| First Submitted that Met QC Criteria : | July 21, 2023 |
| First Posted : | August 1, 2023 |
| Last Update Submitted that Met QC Criteria : | May 16, 2024 |
| Last Update Posted : | May 20, 2024 (Estimate) |